F H Schilling - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

F H Schilling

Showing results (11-20 of 21) with videos related to

Pageof 3

Sort By:

Medical and Pediatric Oncology|December 7, 2000

Population-based and controlled study to evaluate neuroblastoma screening at one year of age in Germany: interim resultsF H Schilling, F Berthold, R Erttmann, et al.

Lancet (London, England)|October 22, 1994

Screening for neuroblastomaF H Schilling, R Erttmann, P F Ambros, et al.

Klinische Padiatrie|July 1, 1990

[The role of interferons in neuroblastoma. 1: Antiproliferative effects]G Bruchelt, R Handgretinger, K Schilbach-Stückle, et al.

Studies in Health Technology and Informatics|February 24, 2001

Requirements and design aspects of a data model for a data dictionary in paediatric oncologyA Merzweiler, P Knaup, U Creutzig, et al.

Cancer Letters|July 26, 2003

Long-term results and risk profiles of patients in five consecutive trials (1979-1997) with stage 4 neuroblastoma over 1 year of ageF Berthold, B Hero, B Kremens, et al.

The American Journal of Pediatric Hematology/Oncology|January 1, 1991

Neuroblastoma screening: arguments from retrospective analysis of three German neuroblastoma trialsF Berthold, D H Hunneman, H Käser, et al.

Medical and Pediatric Oncology|December 7, 2000

Combined (111)In-pentetreotide scintigraphy and (123)I-mIBG scintigraphy in neuroblastoma provides prognostic informationF H Schilling, H Bihl, H Jacobsson, et al.

Medical and Pediatric Oncology|July 24, 2001

Absence of somatostatin receptor expression in vivo is correlated to di- or tetraploid 1p36-deleted neuroblastomasF H Schilling, P F Ambros, H Bihl, et al.

European Journal of Cancer (Oxford, England : 1990)|March 28, 1998

Somatostatin in neuroblastoma and ganglioneuromaP Kogner, P Borgström, P Bjellerup, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2020

Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HRF Berthold, A Faldum, A Ernst, et al.

Pageof 3

Search research articles

Showing results (11-20 of 21) with videos related to

Sort By:

Pageof 3

Medical and Pediatric Oncology|December 7, 2000

Population-based and controlled study to evaluate neuroblastoma screening at one year of age in Germany: interim resultsF H Schilling, F Berthold, R Erttmann, et al.

Lancet (London, England)|October 22, 1994

Screening for neuroblastomaF H Schilling, R Erttmann, P F Ambros, et al.

Klinische Padiatrie|July 1, 1990

[The role of interferons in neuroblastoma. 1: Antiproliferative effects]G Bruchelt, R Handgretinger, K Schilbach-Stückle, et al.

Studies in Health Technology and Informatics|February 24, 2001

Requirements and design aspects of a data model for a data dictionary in paediatric oncologyA Merzweiler, P Knaup, U Creutzig, et al.

Cancer Letters|July 26, 2003

Long-term results and risk profiles of patients in five consecutive trials (1979-1997) with stage 4 neuroblastoma over 1 year of ageF Berthold, B Hero, B Kremens, et al.

The American Journal of Pediatric Hematology/Oncology|January 1, 1991

Neuroblastoma screening: arguments from retrospective analysis of three German neuroblastoma trialsF Berthold, D H Hunneman, H Käser, et al.

Medical and Pediatric Oncology|December 7, 2000

Combined (111)In-pentetreotide scintigraphy and (123)I-mIBG scintigraphy in neuroblastoma provides prognostic informationF H Schilling, H Bihl, H Jacobsson, et al.

Medical and Pediatric Oncology|July 24, 2001

Absence of somatostatin receptor expression in vivo is correlated to di- or tetraploid 1p36-deleted neuroblastomasF H Schilling, P F Ambros, H Bihl, et al.

European Journal of Cancer (Oxford, England : 1990)|March 28, 1998

Somatostatin in neuroblastoma and ganglioneuromaP Kogner, P Borgström, P Bjellerup, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2020

Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HRF Berthold, A Faldum, A Ernst, et al.

Pageof 3